These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2846094)

  • 1. Therapy of patients with human T-cell lymphotrophic virus I-induced adult T-cell leukemia with anti-Tac, a monoclonal antibody to the receptor for interleukin-2.
    Waldmann TA; Goldman CK; Bongiovanni KF; Sharrow SO; Davey MP; Cease KB; Greenberg SJ; Longo DL
    Blood; 1988 Nov; 72(5):1805-16. PubMed ID: 2846094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interleukin-2 receptor: a target for monoclonal antibody treatment of human T-cell lymphotrophic virus I-induced adult T-cell leukemia.
    Waldmann TA; White JD; Goldman CK; Top L; Grant A; Bamford R; Roessler E; Horak ID; Zaknoen S; Kasten-Sportes C
    Blood; 1993 Sep; 82(6):1701-12. PubMed ID: 8400227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
    Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
    Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-IL-2 receptor monoclonal antibody (anti-Tac) treatment of T-cell lymphoma.
    Waldmann TA
    Important Adv Oncol; 1994; ():131-41. PubMed ID: 8206486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunotherapy of interleukin-2R alpha-expressing adult T-cell leukemia with Yttrium-90-labeled anti-Tac.
    Waldmann TA; White JD; Carrasquillo JA; Reynolds JC; Paik CH; Gansow OA; Brechbiel MW; Jaffe ES; Fleisher TA; Goldman CK; Top LE; Bamford R; Zaknoen E; Roessler E; Kasten-Sportes C; England R; Litou H; Johnson JA; Jackson-White T; Manns A; Hanchard B; Junghans RP; Nelson DL
    Blood; 1995 Dec; 86(11):4063-75. PubMed ID: 7492762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphokine receptors: a target for immunotherapy of lymphomas.
    Waldmann TA
    Ann Oncol; 1994; 5 Suppl 1():13-7. PubMed ID: 8172810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1992 Stohlman Memorial Lecture: targeting the IL-2 receptor.
    Waldmann TA
    Leukemia; 1993 Aug; 7 Suppl 2():S151-6. PubMed ID: 8361223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel interleukin-2 dependent T-cell line derived from adult T-cell leukemia not associated with human T-cell leukemia virus type I.
    Kagami Y; Tobinai K; Kinoshita T; Nagai H; Hotta T; Seto M; Ueda R; Saito H
    Jpn J Cancer Res; 1993 Apr; 84(4):371-8. PubMed ID: 8390425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-2 receptor (Tac antigen) expressed on adult T cell leukemia cells.
    Uchiyama T; Hori T; Tsudo M; Wano Y; Umadome H; Tamori S; Yodoi J; Maeda M; Sawami H; Uchino H
    J Clin Invest; 1985 Aug; 76(2):446-53. PubMed ID: 2993359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-2 receptor expression in retrovirus associated adult T-cell leukemia.
    Waldmann TA; Leonard WJ; Depper JM; Krönke M; Goldman CK; Oh T; Greene WC
    Princess Takamatsu Symp; 1984; 15():259-68. PubMed ID: 6100644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult T leukemia cells produce a lymphokine that augments interleukin 2 receptor expression.
    Teshigawara K; Maeda M; Nishino K; Nikaido T; Uchiyama T; Tsudo M; Wano Y; Yodoi J
    J Mol Cell Immunol; 1985; 2(1):17-26. PubMed ID: 2978223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult T cell leukemia: a potential target for ricin A chain immunotoxins.
    Krönke M; Depper JM; Leonard WJ; Vitetta ES; Waldmann TA; Greene WC
    Blood; 1985 Jun; 65(6):1416-21. PubMed ID: 2986744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 2 receptor (Tac antigen) expression in HTLV-I-associated adult T-cell leukemia.
    Waldmann TA; Longo DL; Leonard WJ; Depper JM; Thompson CB; Krönke M; Goldman CK; Sharrow S; Bongiovanni K; Greene WC
    Cancer Res; 1985 Sep; 45(9 Suppl):4559s-4562s. PubMed ID: 2990687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of anti-Tac and anti-transferrin receptor-conjugated liposomes for specific drug delivery to adult T-cell leukemia.
    Hege KM; Daleke DL; Waldmann TA; Matthay KK
    Blood; 1989 Nov; 74(6):2043-52. PubMed ID: 2679914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional and phenotypic comparison of human T cell leukemia/lymphoma virus positive adult T cell leukemia with human T cell leukemia/lymphoma virus negative Sézary leukemia, and their distinction using anti-Tac. Monoclonal antibody identifying the human receptor for T cell growth factor.
    Waldmann TA; Greene WC; Sarin PS; Saxinger C; Blayney DW; Blattner WA; Goldman CK; Bongiovanni K; Sharrow S; Depper JM
    J Clin Invest; 1984 Jun; 73(6):1711-8. PubMed ID: 6327770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal expression of interleukin-2 receptor (Tac antigen) in adult T-cell leukemia.
    Uchiyama T; Wano Y; Tsudo M; Umadome H; Hori T; Tamori S; Uchino H; Yodoi J; Maeda M; Kobayashi N
    Princess Takamatsu Symp; 1984; 15():253-8. PubMed ID: 6100643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Tac-H, a humanized antibody to the interleukin 2 receptor with new features for immunotherapy in malignant and immune disorders.
    Junghans RP; Waldmann TA; Landolfi NF; Avdalovic NM; Schneider WP; Queen C
    Cancer Res; 1990 Mar; 50(5):1495-502. PubMed ID: 2406013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interleukin-2 receptor on malignant cells: a target for diagnosis and therapy.
    Waldmann TA
    Cell Immunol; 1986 Apr; 99(1):53-60. PubMed ID: 3019574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometric analysis of expression of interleukin-2 receptor beta chain (p70-75) on various leukemic cells.
    Hoshino S; Oshimi K; Tsudo M; Miyasaka M; Teramura M; Masuda M; Motoji T; Mizoguchi H
    Blood; 1990 Aug; 76(4):767-74. PubMed ID: 2383656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The promiscuous IL-2/IL-15 receptor: a target for immunotherapy of HTLV-I-associated disorders.
    Waldmann TA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 13 Suppl 1():S179-85. PubMed ID: 8797721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.